Novel Coumarin-Quinoline Hybrids: Design of Multitarget Compounds for Alzheimer's Disease

dc.creatorDuarte Y.
dc.creatorFonseca A.
dc.creatorGutiérrez M.
dc.creatorAdasme-Carreño F.
dc.creatorMuñoz-Gutierrez C.
dc.creatorAlzate-Morales J.
dc.creatorSantana L.
dc.creatorUriarte E.
dc.creatorÁlvarez R.
dc.creatorMatos M.J.
dc.date.accessioned2020-09-02T22:16:41Z
dc.date.accessioned2022-11-08T20:21:39Z
dc.date.available2020-09-02T22:16:41Z
dc.date.available2022-11-08T20:21:39Z
dc.date.created2020-09-02T22:16:41Z
dc.date.issued2019
dc.identifier4, 2, 551-558
dc.identifier23656549
dc.identifierhttps://hdl.handle.net/20.500.12728/4291
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5144104
dc.languageen
dc.publisherWiley-Blackwell
dc.subjectAcetyl/butyrylcholinesterases’ inhibitors
dc.subjectCoumarin-quinoline hybrids
dc.subjectDrug design
dc.subjectIron chelating agents
dc.subjectNeuroprotective agents.
dc.titleNovel Coumarin-Quinoline Hybrids: Design of Multitarget Compounds for Alzheimer's Disease
dc.typeArticle


Este ítem pertenece a la siguiente institución